NEW YORK — Fans of the Netflix crime documentary “Making A Murderer” may soon have another series to binge watch.
Laura Ricciardi and Moira Demos, filmmakers of last year’s popular crime documentary, have chosen pharmaceutical giant Johnson & Johnson as the subject of their next project, according to multiple reports.
It will be the first project under the deal between Sonar Entertainment and Smokehouse Pictures — the property of Grant Heslov and George Clooney.
A network has yet to be attached to the project, and it’s unclear how many episodes will make up the series.
The made-for-TV project will reportedly be an adaption of ‘America’s Most Admired Lawbreaker‘ — based on the Huffington Post series of articles by journalist Steven Brill.
It marks the first project for Ricciardi and Demos since they teamed up to create “Making A Murderer,” a documentary about Steven Avery, who served 18 years in prison before he was exonerated, only to be arrested two years later and convicted for the death of a photographer.
“Lawbreaker” is the true story of a venerable pharmaceutical company that created a dangerous drug and marketed it aggressively to children and the elderly while allegedly manipulating and hiding data about its side effects. The project will highlight the controversy surrounding Johnson & Johnson, who pushed Risperdal on elderly patients and children.
Risperdal was approved by the U.S. Food and Drug Administration in 1993 as a powerful drug to combat adult schizophrenia — not to treat any ailments in children or the elderly.
The project is expected focus on the litigation brought against Johnson & Johnson after, as reported by cinemablend, a suspicious employee contacted attorney Stephen Sheller and became a whistleblower against the pharmaceutical giant. Johnson & Johnson agreed to pay more than $2 billion in penalties and settlements, but made a reported $30 billion in sales of the drug worldwide.
Sonar Partners With Clooney’s Smokehouse Pictures
“America’s Most Admired Lawbreaker” will be the first project under the deal between Sonar Entertainment and Smokehouse Pictures — the property of Grant Heslov and George Clooney.
“We couldn’t be more excited to be in business with George and Grant and their talented team at Smokehouse,” Sonar CEO Thomas Lesinski told The Hollywood Reporter. “Smokehouse has a stellar track record of delivering commercial and critically acclaimed content. Smokehouse will be a great partner for Sonar Entertainment, as the two companies align perfectly in our approaches to premium TV programming.”
Smokehouse Pictures staple Nicki Paluga, whose credits include ‘Resurrection’ and ‘Perception’, will reportedly be tasked with adapting the 15-page ‘America’s Most Admired Lawbreaker’ into a undetermined film or series.
Smokehouse Pictures has gained a track record of producing critically acclaimed films including ‘Argo’ and ‘August: Osage County’.
Smokehouse also boasts production credit on major Clooney films including: ‘Leatherheads’, ‘The Men Who Stare at Goats’, and ‘Monuments Men’.
How Bad Is Risperdal For Elderly Patients, Children?
Risperdal is an immensely powerful anti-psychotic drug that targets serotonin and dopamine receptors in the brain.
While the development of breasts in young males became a hot-button issue, garnering major media coverage during the Johnson & Johnson lawsuit, studies have uncovered multiple life threatening side effects that can develop in all Risperdal users. Most concerning of these discoveries has been the rate in which elderly patients taking Risperdal face death as a result of developing one of the many drug related side effects.
More than 40 studies spanning eight countries found that weight gain, heart problems, diabetes and strokes developed at an alarming rate in Risperdal users — particularly the elderly. These health complications would develop unbeknownst to the drug user, frequently leading to life threatening situations for individuals.
Risperdal’s potential damage to consumers both young and old has led to 16 drug regulatory agencies issuing warnings that go as far as explicitly stating that elderly patients with dementia should not under any circumstance take Risperdal due to the risk of death.
Warnings and studies were published during Johnson & Johnson litigation and continue to be published today. However, even during the litigation process in which deadly side effects were being reported in thousands of consumers, Johnson & Johnson refused to take any action to save lives and continued to push their drug on children and elderly patients.